Aripiprazole effects in patients with acute schizophrenia
experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials.
These trials established the efficacy of cariprazine for acute schizophrenia
at dos ages ranging from 1.
A Head Full of Ghosts tells of a normal New England family whose lives are transformed when their teenager begins to display signs of acute schizophrenia
Although as an acute schizophrenia
trial, ITI-007-005 was not designed to look just at negative symptoms of schizophrenia, the investigators predefined a subgroup population analysis of patients who had prominent negative symptoms at baseline (defined as a score of 4 or more on at least three negative symptom items on the PANSS at baseline).
Summary: Some politicians in Lebanon suffer from acute schizophrenia
They're all victims of the show's acute schizophrenia
that reared its ugly head with barbarity in week one, when Fil "with an F" Henley swaggered in with all the rock-star charisma of Ronnie Corbett and made a total illock-with-a-P of himself.
He told the court through a translator that he heard voices - a result of his acute schizophrenia
At this time, the best that we are able to conclude about the relative efficacy of the three new SGAs is that all are superior to placebo in the acute treatment of acute schizophrenia
, and, in the case of Saphris, manic or mixed episodes associated with bipolar I disorder.
According to the review, the mother's mental health deteriorated and she was diagnosed with acute schizophrenia
The criteria for inclusion in the Depression in Acute Schizophrenia
(DepASch) and Depression in Chronic Schizophrenia (DepChrSch) groups were based on screening of individuals with known schizophrenia.
One in 100 people will experience at least one episode of acute schizophrenia
during their lifetime.
11 March 2010 - Dainippon Sumitomo Pharma America Inc (DSPA), a US subsidiary of Japanese Dainippon Sumitomo Pharma Co Ltd (TYO: 4506), said yesterday that the US Food and Drug Administration (FDA) has recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia